Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study
Authors:
Open Access
- 28 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (14) , e139
Abstract
Baculovirus (BV) is a promising gene vector but mediates transient expression. To prolong the expression, we developed a binary system whereby the transgene in the substrate BV was excised by the recombinase (ΦC31o, Cre or FLPo) expressed by a second BV and recombined into smaller minicircle. The recombination efficiency was lower by ΦC31o (≈40–75%), but approached ≈90–95% by Cre and FLPo in various cell lines and stem cells [e.g. human adipose-derived stem cells (hASCs)]. Compared with FLPo, Cre exerted higher expression level and lower negative effects; thus, we incorporated additional cis-acting element [oriP/Epstein–Barr virus nuclear antigen 1 (EBNA1), scaffold/matrix attached region or human origin of replication (ori)] into the Cre-based BV system. In proliferating cells, only oriP/EBNA1 prolonged the transgene expression and maintained the episomal minicircles for 30 days without inadvertent integration, whereas BV genome was degraded in 10 days. When delivering bmp2 or vegf genes, the efficient recombination/minicircle formation prolonged and enhanced the growth factor expression in hASCs. The prolonged bone morphogenetic protein 2 expression ameliorated the osteogenesis of hASCs, a stem cell with poor osteogenesis potential. Altogether, this BV vector exploiting Cre-mediated recombination and oriP/EBNA1 conferred remarkably high recombination efficiency, which prolonged and enhanced the transgene expression in dividing and non-dividing cells, thereby broadening the applications of BV.Keywords
This publication has 60 references indexed in Scilit:
- Lentiviral Vector Induced Insertional Haploinsufficiency of Ebf1 Causes Murine LeukemiaMolecular Therapy, 2012
- Multiple new site-specific recombinases for use in manipulating animal genomesProceedings of the National Academy of Sciences, 2011
- Genetic engineering of human pluripotent cells using TALE nucleasesNature Biotechnology, 2011
- Site-specific Gene Insertion Mediated by a Cre-loxP-carrying Lentiviral VectorMolecular Therapy, 2010
- Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent miceGene Therapy, 2010
- A nonviral minicircle vector for deriving human iPS cellsNature Methods, 2010
- Development of a Hybrid Baculoviral Vector for Sustained Transgene ExpressionMolecular Therapy, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen speciesProceedings of the National Academy of Sciences, 2009
- Targeted gene addition into a specified location in the human genome using designed zinc finger nucleasesProceedings of the National Academy of Sciences, 2007